Navigation Links
New Oral Anticoagulants Markets
Date:3/25/2013

c Agents 143
6.7.7.2 Reasons for Increased Clot Risk after Surgery 143
6.8 Prophylactic Anticoagulation after a Hip Fracture 143
6.8.1 Pharmacologic Prevention of Blood Clots after a Hip Fracture 144
6.8.1.1 Aspirin 144
6.8.1.2 Warfarin 144
6.8.1.3 Heparins 144
6.8.1.4 Fondaparinux 145
6.8.2 Duration of Prophylaxis after Hip Fracture 145
6.9 Pulmonary Embolism (Blood Clot in the Lung) 145
6.9.1 Signs and Symptoms of Pulmonary Embolism 146
6.9.2 Anticoagulation Therapy for Pulmonary Embolism 146
6.10 Oral Surgery and Anticoagulation Therapy 147
6.10.1 Required Laboratory Investigations for Dental Patients on Anticoagulation 147
6.11 Hemodialysis 147
6.11.1 Global Market for Hemodialysis 148
6.11.2 Global Operators of Dialysis Clinics 148
6.11.3 Global Leaders in Hemodialysis Products 149
6.11.4 Global Leaders in Peritoneal Dialysis Products 150
6.11.5 Anticoagulation in Hemodialysis 151
6.12 Cancer 151
6.12.1 Global Market for Cancer Therapeutics 152
6.12.2 The Cancer-Thrombosis Connection 152

7. Market Analysis: Anticoagulants 154
7.1 Overview of this Chapter 154
7.2 Oral Anticoagulants 156
7.2.1 Vitamin K Antagonists 157
7.2.1.1 Global Market for Warfarin 158
7.2.1.2 The Threatened Position of Warfarin in the Anticoagulants Market 159
7.2.1.3 Newer Oral Anticoagulants to Replace Warfarin 160
7.2.1.4 Potential Alternatives to Warfarin 160
7.2.2 Factor Xa Inhibitors 160
7.2.2.1 Global Market for Factor Xa Inhibitors 160
7.2.3 Global Market for Xarelto (Rivaroxaban) 161
7.2.3.1 Xarelto: A Great Promise 162
7.2.3.2 U.S. Market for Xarelto 162
7.2.3.3 U.S. Market Share for Eliquis, Xarelto and Pradaxa 163
7.2.4 Direct Thrombin Inhibitors (DTI) 164
7.2.4.1 Global Market for Direct Thrombin Inhibitors 165
7.2.5 Global Market for Pradaxa (Dabigatran) 166
7.2.5.1 Dawning of the Age of Dabigatran 167
7.2.5.2 Pr
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Global Anticoagulants Industry
2. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
3. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
4. Global Ablation Technologies Market worth $12.4 Billion by 2016: MarketsandMarkets
5. Frost & Sullivan Research Preview: Top 20 Telehealth Markets
6. MarketsandMarkets: Global Endoscopy Market worth $9.7 Billion by 2016
7. Transdermal Hormone Replacement: Products, Players, Markets and Forecasts
8. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
9. Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare
10. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
11. Emerging Markets for Enzyme Inhibitors Surge, To Grow More Than 50% by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... -- MEDITE Group acquired by CytoCore, Inc. (OTCBB: CYOE) on ... quarter sales ended September 30, 2014 of $8.7 million ... months ended September 2014 and a $38,000 loss for the ... quarter is usually a seasonable weak period due to the ... many countries worldwide, we are proud to announce record sales ...
(Date:11/22/2014)... DUBLIN , Nov. 21, 2014 Research ... "China Recombinant Protein Drug Industry Report, 2014-2017" report ... The Chinese recombinant protein drug market ... demand rigidity, consumption ability and the like. During 2005-2013, ... hospitals grew at a CAGR of 19.1%, and it ...
(Date:11/21/2014)... Mass. , Nov. 21, 2014  Alere Inc. ... rapid diagnostic tests, has appointed Juliet Cunningham ... role, Cunningham will be responsible for driving communications with ... execute on a series of changes to increase shareholder ... progress to investors," said Namal Nawana, Chief Executive Officer. ...
Breaking Medicine Technology:CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Alere Appoints Juliet Cunningham to Lead Investor Relations 2
... (Polaris) today announced that it has dosed the first ... lead cancer therapeutic, pegylated arginine deiminase (ADI-PEG 20), in ... cancers. These three cancers represent approximately 50% of all ... Patients with advanced cancers who have failed current therapy ...
... Inc. (Nasdaq: MSHL ), an oncology company ... cancer metabolism, announced today that Daniel P. Gold, Ph.D., ... on Marshall Edwards and the clinical development of its ... Roth Capital Partners Growth Stock Conference on Wednesday, March ...
Cached Medicine Technology:Polaris Group Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Pediatric Patients with Emphasis on Leukemia, Lymphoma and Sarcoma 2Polaris Group Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Pediatric Patients with Emphasis on Leukemia, Lymphoma and Sarcoma 3Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference 2
(Date:11/23/2014)... 21, 2014 (HealthDay News) -- Close friends have more ... group does, a new study says. "We,ve ... have an influence on individual alcohol use, but there ... peer group and the friend group,s influence on those ... School of Public Health, said in a university news ...
(Date:11/23/2014)... To show thanks to new and old customers, iFitDress.com ... dresses for weddings. Customers who need custom outfits can ... distinguished dress manufacturer, and it is among the ones which ... very long time. The CEO of this company says, "iFitDress.com ... to buy not only a beautiful dress, but also a ...
(Date:11/23/2014)... CA (PRWEB) November 23, 2014 ... American Medical Aesthetics & Wellness was recently featured ... Milgrom, Ph.D. is president and CEO of American Medical ... Dr. Asher Milgrom received a full scholarship to attend ... the Medical School at the University of Chicago, where ...
(Date:11/23/2014)... Wright & Schulte LLC recently filed 40 C8 ... residents who allege that they developed thyroid disease, high ... C8 contaminated water released by the DuPont Washington ... C8 complaints, the plaintiffs were exposed to the C8 ... least one of the six water districts affected by ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 A new ... its doors in the downtown Greenville area. Dr. Chelsea ... Greenville , decided to open her own clinic after ... results with the patients. , AlignLife believes that ... tools. With a focus on chiropractic care and rehabilitation ...
Breaking Medicine News(10 mins):Health News:Close Friends May Be Key to Teens' Drinking 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 2Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 3Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 4Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2
... , CALL DATE: ... TIME: 8:30 a.m. Eastern ... Dr. Candace Kendle, Chairman and CEO Kendle ... at 8:30 a.m. Eastern Time to discuss its,financial results for the Fourth Quarter and ...
... Stryker Corporation,(NYSE: SYK ) announced today that it ... at 8:00 a.m. Eastern Time, in New York, New ... Officer, will host,the meeting with presentations by leaders of ... the meeting will be available on Stryker,s,website at ...
... 30 Crowell & Moring LLP is,pleased to announce ... New,York office as a member of the firm,s Antitrust ... where she helped found and co-chair,the firm,s Healthcare Industry ... Federal Trade Commission (FTC), where she investigated and,prosecuted mergers, ...
... Jan. 30 More than 100 local VIPS,physicians and ... of America (DCA) Delray Beach medical facility to commemorate ... imaging, enabling physicians to obtain clearer images of the ... without the need for beta blockers., Mayor Rita ...
... Partners Purchase Interest from American ... Securities Capital Partners, ... Ganey,Associates, Inc., the leading provider of health care performance,improvement solutions, ... a majority interest in the Company from,long-time investor American Securities ...
... SILVER SPRING, Md., Jan. 30 Expanding the,pipeline ... for Microbicides (IPM) today announced that Pfizer Inc.,(Pfizer) ... to maraviroc, its,newly-approved HIV treatment, as a microbicide ... the trade name Selzentry(TM)/Celsentri(R),is one of a new ...
Cached Medicine News:Health News:Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast 2Health News:Stryker to Host Analyst Meeting 2Health News:Former FTC Attorney Christine White Joins Crowell & Moring's Health Care and Antitrust Groups 2Health News:Former FTC Attorney Christine White Joins Crowell & Moring's Health Care and Antitrust Groups 3Health News:Delray Beach Mayor Commemorates Diagnostic Centers of America (DCA) $2 Million Purchase from Siemens to Become Only Medical Facility in South Florida with World's Most Advanced Cardiac Scanner. 2Health News:Press Ganey Takes on New Investment Partner 2Health News:Press Ganey Takes on New Investment Partner 3Health News:Press Ganey Takes on New Investment Partner 4Health News:IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide 2Health News:IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide 3
... Bright and playful, ... is perfect for girls ... fun.Trendy shapes, colorful accents ... flare to this exciting ...
... man. Includes an opthalmic collection that is ... a sunglass collection that will soon be ... divided into two parts named "Jhane Barnes ... use ophthalmic styles using cutting edge technology ...
... Thalia eyeglasses eyewear collection reflects ... of the renowned Latin singer/actress ... eyeglasses eyewear is ultra-sleek, fashionable, ... styles that include decorative details ...
... Silhouette has put together a remarkable ... . This collection combines all of the ... screwless and hingeless designs with top quality ... B and C radiation protection. They provide ...
Medicine Products: